Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. Read my analysis on RXRX here.

Samsung’s AI lab in Montreal new Tiny Recursive Model with only 7M parameters performs as well, if not better in some instances, than systems much larger.

WASHINGTON, Sept 15 (Reuters) - A year from now the United States may have emerged from the economic hole dug during the pandemic with growth smartly above its previous trend and output largely ...

Type B flu is unusually common this season. If you've been infected with type B flu, you're still susceptible to contracting type A and vice versa.